Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Clin Cancer Res. 2008 Aug 1;14(15):4850–4858. doi: 10.1158/1078-0432.CCR-07-4065

Figure 2.

Figure 2

Immune Responses to influenza (A–C), tumor peptide DC vaccines (D) and E7 peptide DC vaccine shown for HLA-A2+ patients only (E). IFN·: interferon gamma; chemoRx: chemotherapy; immunoRx: immunotherapy; Dashed line shows threshold of positivity determined prior to protocol initiation.